Thermo Fisher Scientific reported a 3% year-over-year revenue increase to $10.86 billion in Q2, surpassing analyst estimates with a 6% rise in life sciences solutions revenue. Net income reached $1.62 billion with adjusted EPS above consensus. The company announced CFO Stephen Williamson will retire in 2026, with Jim Meyer named as his successor. The results reflect steady execution amid macroeconomic challenges, positioning Thermo Fisher to meet its 2025 targets.